Drug trafficking in Europe changes as expertise in synthetic drug production increases

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f758 (Published 6 February 2013)
Cite this as: BMJ 2013;346:f758

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Rory Watson
  1. 1Brussels

Europe’s illicit drugs trade is entering a new era, forcing policy makers to rethink their responses, says a report commissioned by Cecilia Malmström, the European commissioner for home affairs.1

Historically, the illicit drug market in Europe centred on specific drugs trafficked by specialised operators along well defined routes. Now experts note that the market is far more fluid as new routes and multi-substance consignments become more common.

Commenting on the findings, Malmström said, “Drug markets are evolving, and we need …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL